CI RSI Chart
Last 7 days
-0.1%
Last 30 days
3.1%
Last 90 days
18.0%
Trailing 12 Months
30.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 183.0B | 186.1B | 189.9B | 195.3B |
2022 | 177.1B | 179.5B | 180.4B | 180.5B |
2021 | 162.9B | 166.8B | 170.1B | 174.1B |
2020 | 154.1B | 154.5B | 156.9B | 160.4B |
2019 | 75.2B | 102.5B | 129.6B | 153.6B |
2018 | 42.8B | 43.9B | 45.0B | 48.6B |
2017 | 40.3B | 40.8B | 41.3B | 41.8B |
2016 | 0 | 0 | 0 | 39.8B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 25, 2024 | cordani david | acquired | 4,344,920 | 139 | 31,209 | chairman & ceo |
Mar 25, 2024 | cordani david | sold | -11,084,400 | 355 | -31,209 | chairman & ceo |
Mar 22, 2024 | cordani david | acquired | 882,376 | 139 | 6,338 | chairman & ceo |
Mar 22, 2024 | cordani david | sold | -2,250,680 | 355 | -6,338 | chairman & ceo |
Mar 21, 2024 | cordani david | acquired | 319,231 | 139 | 2,293 | chairman & ceo |
Mar 21, 2024 | cordani david | sold | -814,052 | 355 | -2,293 | chairman & ceo |
Mar 14, 2024 | cordani david | acquired | 1,060,300 | 139 | 7,616 | chairman & ceo |
Mar 13, 2024 | cordani david | acquired | 1,915,810 | 139 | 13,761 | chairman & ceo |
Mar 13, 2024 | cordani david | sold | -4,779,540 | 347 | -13,761 | chairman & ceo |
Mar 12, 2024 | cordani david | sold | -772,121 | 345 | -2,238 | chairman & ceo |
Which funds bought or sold CI recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 26, 2024 | Fairman Group, LLC | new | - | 10,481 | 10,481 | 0.01% |
Mar 26, 2024 | HighPoint Advisor Group LLC | new | - | 2,046,000 | 2,046,000 | 0.15% |
Mar 22, 2024 | Livelsberger Financial Advisory | new | - | 2,995 | 2,995 | -% |
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -7.5 | -3,869,920 | 118,061,000 | 0.09% |
Mar 21, 2024 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | reduced | -35.29 | -3,138,480 | 6,587,900 | 0.02% |
Mar 18, 2024 | CoreFirst Bank & Trust | reduced | -6.01 | -10,747 | 655,796 | 0.44% |
Mar 15, 2024 | B. Riley Wealth Advisors, Inc. | reduced | -10.88 | -140,135 | 1,949,500 | 0.05% |
Mar 14, 2024 | Leo Wealth, LLC | new | - | 625,441 | 625,441 | 0.06% |
Mar 14, 2024 | ABLES, IANNONE, MOORE & ASSOCIATES, INC. | new | - | 15,571 | 15,571 | 0.01% |
Mar 13, 2024 | MONECO Advisors, LLC | new | - | 574,046 | 574,046 | 0.11% |
Unveiling Cigna Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index
Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.
Returns of $10,000 invested in:
Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022
Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.
Peers (Alternatives to Cigna Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 454.6B | 371.6B | 20.31 | 1.22 | ||||
CI | 106.2B | 195.3B | 19.78 | 0.54 | ||||
CVS | 100.0B | 357.8B | 11.97 | 0.28 | ||||
HCA | 87.7B | 65.0B | 16.74 | 1.35 | ||||
CNC | 41.9B | 154.0B | 15.51 | 0.27 | ||||
UHS | 12.6B | 14.3B | 17.56 | 0.88 | ||||
DVA | 12.0B | 12.1B | 17.36 | 0.99 | ||||
MID-CAP | ||||||||
CHE | 9.7B | 2.3B | 35.74 | 4.3 | ||||
ACHC | 7.2B | 2.9B | -333.68 | 2.47 | ||||
AMN | 2.3B | 3.8B | 11.05 | 0.61 | ||||
AMEH | 2.2B | 1.4B | 36.06 | 1.58 | ||||
SMALL-CAP | ||||||||
ADUS | 1.7B | 1.1B | 26.93 | 1.59 | ||||
BKD | 1.2B | 3.0B | -6.6 | 0.41 | ||||
BEAT | 56.3M | - | -3.85 | - | ||||
AMS | 16.9M | 20.7M | 83.48 | 0.82 |
Cigna Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 4.2% | 51,114 | 49,048 | 48,586 | 46,517 | 45,753 | 45,281 | 45,478 | 44,006 | 45,679 | 44,288 | 43,131 | 40,971 | 41,712 | 40,955 | 39,265 | 38,469 | 38,245 | 38,556 | 38,819 | 37,946 | 14,300 |
S&GA Expenses | 7.2% | 4,062 | 3,788 | 3,434 | 3,538 | 3,484 | 3,151 | 3,264 | 3,275 | 3,644 | 3,093 | 2,996 | 3,279 | 3,966 | 3,301 | 3,407 | 3,398 | 3,957 | 3,413 | 3,380 | 3,303 | 3,480 |
EBITDA Margin | -12.8% | 0.05* | 0.06* | 0.07* | 0.07* | 0.07* | 0.07* | 0.06* | 0.06* | 0.06* | 0.09* | 0.09* | 0.09* | - | - | - | - | - | - | - | - | - |
Interest Expenses | -19.6% | 311 | 387 | 310 | 322 | 306 | 308 | 307 | 308 | 303 | 311 | 308 | 331 | 327 | 369 | 348 | 395 | 388 | 392 | 488 | 377 | 100 |
Income Taxes | -335.0% | -919 | 391 | 374 | 295 | 136 | 713 | 411 | 355 | 182 | 424 | 422 | 342 | 1,236 | 406 | 529 | 208 | 277 | 409 | 348 | 416 | 81.00 |
Earnings Before Taxes | -89.8% | 188 | 1,840 | 1,884 | 1,601 | 1,358 | 3,491 | 1,981 | 1,567 | 1,320 | 2,059 | 1,898 | 1,513 | 5,378 | 1,804 | 2,289 | 1,397 | 1,261 | 1,763 | 1,758 | 1,788 | 228 |
EBT Margin | -19.8% | 0.03* | 0.04* | 0.04* | 0.05* | 0.05* | 0.05* | 0.04* | 0.04* | 0.04* | 0.06* | 0.06* | 0.07* | - | - | - | - | - | - | - | - | - |
Net Income | -23.6% | 1,107 | 1,449 | 1,510 | 1,306 | 1,222 | 2,778 | 1,570 | 1,212 | 1,138 | 1,635 | 1,476 | 1,171 | 4,142 | 1,398 | 1,760 | 1,189 | 977 | 1,354 | 1,410 | 1,372 | 144 |
Net Income Margin | -4.8% | 0.03* | 0.03* | 0.04* | 0.04* | 0.04* | 0.04* | 0.03* | 0.03* | 0.03* | 0.05* | 0.05* | 0.05* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -48.1% | 1,467 | 2,826 | 2,182 | 4,718 | 1,789 | 2,973 | 934 | 1,720 | 3,965 | 1,809 | -606 | 783 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 2.1% | 152,761 | 149,645 | 150,054 | 147,976 | 143,885 | 144,209 | 152,630 | 152,610 | 154,889 | 154,251 | 154,207 | 152,081 | 155,451 | 160,044 | 159,628 | 154,711 | 155,774 | 154,847 | 154,401 | 154,348 | 153,226 |
Current Assets | 8.2% | 37,351 | 34,518 | 34,711 | 32,027 | 30,122 | 30,170 | 37,422 | 35,393 | 36,134 | 25,487 | 25,011 | 25,554 | 27,799 | 34,557 | 34,880 | 30,877 | 29,845 | 21,168 | 20,709 | 21,136 | 20,430 |
Cash Equivalents | -7.9% | 7,822 | 8,497 | 9,585 | 7,935 | 5,924 | 7,117 | 4,468 | 4,469 | 5,123 | 3,540 | 3,878 | 6,544 | 4,157 | 5,406 | 7,185 | 4,452 | - | 4,577 | 3,610 | 4,976 | 243 |
Inventory | 27.8% | 5,645 | 4,416 | 4,514 | 4,211 | 4,777 | 4,017 | 3,781 | 3,500 | 3,722 | 3,020 | 3,042 | 2,919 | 3,165 | 2,657 | 2,712 | 2,565 | 2,661 | 2,160 | 2,298 | 2,382 | 2,821 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4,417 | 4,448 | 4,538 | 4,523 | 4,562 |
Goodwill | -3.4% | 44,259 | 45,810 | 45,811 | 45,811 | 45,811 | 45,807 | 45,810 | 45,804 | 45,811 | 46,056 | 46,063 | 44,635 | 44,648 | 44,685 | 44,590 | 44,584 | 44,602 | 44,462 | 44,449 | 44,537 | 44,505 |
Liabilities | 2.4% | 106,410 | 103,879 | 104,528 | 103,380 | 99,131 | 99,076 | 106,663 | 106,446 | 107,705 | 106,768 | 105,440 | 103,867 | 105,065 | 111,946 | 112,223 | 109,590 | 110,395 | 110,114 | 110,552 | 111,897 | 112,154 |
Current Liabilities | 3.5% | 48,716 | 47,059 | 47,345 | 44,727 | 41,225 | 41,115 | 45,218 | 43,662 | 43,572 | 36,340 | 34,711 | 33,470 | 36,022 | 43,886 | 42,179 | 40,380 | 40,138 | 34,447 | 31,867 | 32,969 | 31,895 |
Long Term Debt | 0.2% | 28,155 | 28,094 | 28,115 | 29,124 | 28,100 | 28,090 | 30,984 | 31,013 | 31,125 | 31,609 | 31,606 | 31,568 | 29,545 | 29,537 | 31,774 | 32,147 | 31,893 | 34,041 | 36,885 | 37,571 | 39,523 |
Shareholder's Equity | 1.2% | 46,223 | 45,691 | 45,464 | 44,518 | 44,675 | 44,806 | 45,701 | 46,145 | 46,976 | 47,427 | 48,716 | 48,155 | 50,189 | 48,039 | 47,371 | 45,086 | 45,344 | 44,699 | 43,818 | 42,413 | 41,035 |
Retained Earnings | 1.6% | 41,652 | 40,982 | 39,936 | 38,841 | 37,940 | 37,041 | 34,626 | 33,420 | 32,593 | 31,803 | 30,513 | 29,389 | 28,575 | 24,440 | 23,052 | 21,298 | 20,162 | 19,185 | 17,834 | 16,426 | 15,088 |
Additional Paid-In Capital | 0.3% | 30,669 | 30,563 | 30,436 | 30,332 | 30,233 | 29,395 | 29,930 | 29,736 | 29,574 | 29,077 | 29,403 | 29,254 | 28,975 | 28,777 | 28,699 | 28,554 | 28,306 | 28,115 | 27,891 | 27,855 | 27,751 |
Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 372 | 373 | 378 | 379 | - |
Minority Interest | 90.9% | 21.00 | 11.00 | 19.00 | 16.00 | 13.00 | 42.00 | 30.00 | 22.00 | 18.00 | 12.00 | 7.00 | 6.00 | 7.00 | 7.00 | 5.00 | 7.00 | 6.00 | 3.00 | 3.00 | 5.00 | 7.00 |
Float | - | - | - | 82,800 | - | - | - | 82,800 | - | - | - | 80,800 | - | - | - | 68,900 | - | - | - | 59,400 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -48.1% | 1,467 | 2,826 | 2,492 | 5,028 | 2,099 | 3,283 | 1,244 | 2,030 | 4,275 | 2,119 | -296 | 1,093 | 4,294 | 895 | 3,274 | 1,887 | 2,793 | 2,461 | 1,039 | 3,192 | 126 |
Cashflow From Investing | 67.1% | -440 | -1,337 | -414 | -2,983 | -616 | 4,446 | -408 | -324 | 123 | -710 | -2,307 | -717 | 4,420 | -938 | -237 | -269 | -271 | -304 | -634 | 475 | -24,704 |
Cashflow From Financing | 51.4% | -1,250 | -2,572 | -435 | -37.00 | -2,636 | -5,517 | -916 | -2,171 | -2,371 | -1,728 | -62.00 | -4,051 | -4,721 | -1,682 | -312 | -1,818 | -1,707 | -1,173 | -1,773 | -2,534 | 4,400 |
Dividend Payments | -1.1% | 358 | 362 | 362 | 368 | 334 | 341 | 352 | 357 | 324 | 330 | 342 | 345 | - | - | 15.00 | - | - | - | - | - | - |
Buy Backs | -12.8% | 544 | 624 | 154 | 962 | 1,733 | 3,500 | 1,006 | 1,368 | 1,421 | 2,611 | 916 | 2,794 | 1,690 | 1,028 | 368 | 956 | 447 | 674 | 404 | 462 | 32.00 |
Consolidated Statements of Income - USD ($) $ in Millions | 12 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | [1] | Dec. 31, 2021 | [1] | |||
Revenues | |||||||
Premiums | $ 44,237 | $ 39,916 | $ 41,154 | ||||
Net investment income | 1,166 | 1,155 | 1,549 | ||||
TOTAL REVENUES | 195,265 | 180,518 | 174,069 | ||||
Benefits and expenses | |||||||
Pharmacy and other service costs | 133,801 | 124,834 | 117,553 | ||||
Medical costs and other benefit expenses | 36,287 | 32,184 | 33,565 | ||||
Selling, general and administrative expenses | 14,822 | 13,174 | 13,012 | ||||
Amortization of acquired intangible assets | 1,819 | 1,876 | 1,998 | ||||
TOTAL BENEFITS AND EXPENSES | 186,729 | 172,068 | 166,128 | ||||
Income from operations | 8,536 | 8,450 | 7,941 | ||||
Interest expense and other | (1,446) | (1,228) | (1,208) | ||||
Debt extinguishment costs | 0 | 0 | (141) | ||||
(Loss) gain on sale of businesses | (1,499) | 1,662 | 0 | ||||
Net realized investment (losses) gains | (78) | (487) | 198 | ||||
Income before income taxes | 5,513 | 8,397 | 6,790 | ||||
TOTAL INCOME TAXES | 141 | 1,615 | 1,370 | ||||
Net income | 5,372 | 6,782 | 5,420 | ||||
Less: Net income attributable to noncontrolling interests | 208 | 78 | 50 | ||||
SHAREHOLDERS' NET INCOME | $ 5,164 | $ 6,704 | $ 5,370 | ||||
Shareholders' net income per share | |||||||
Basic (in dollars per share) | $ 17.57 | $ 21.66 | $ 15.89 | ||||
Diluted (in dollars per share) | $ 17.39 | $ 21.41 | $ 15.75 | ||||
Pharmacy revenues | |||||||
Revenues | |||||||
Revenues | $ 137,243 | $ 128,566 | $ 121,413 | ||||
Fees and other revenues | |||||||
Revenues | |||||||
Revenues | $ 12,619 | $ 10,881 | $ 9,953 | ||||
|
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | [1] | ||||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash and cash equivalents | $ 7,822 | $ 5,924 | |||||
Investments | 925 | 905 | |||||
Accounts receivable, net | 17,722 | 17,218 | |||||
Inventories | 5,645 | 4,777 | |||||
Other current assets | 2,169 | 1,298 | |||||
Assets of businesses held for sale | 3,068 | 0 | |||||
Total current assets | 37,351 | 30,122 | |||||
Long-term investments | 17,985 | 16,288 | |||||
Reinsurance recoverables | 4,835 | 5,416 | |||||
Property and equipment | 3,695 | 3,774 | |||||
Goodwill | 44,259 | 45,811 | |||||
Other intangible assets | 30,863 | 32,492 | |||||
Other assets | 3,421 | 2,704 | |||||
Separate account assets | 7,430 | 7,278 | |||||
Assets of businesses held for sale, non-current | 2,922 | 0 | |||||
TOTAL ASSETS | 152,761 | 143,885 | |||||
Liabilities | |||||||
Current insurance and contractholder liabilities | 5,514 | 5,409 | |||||
Pharmacy and other service costs payable | 19,815 | 17,070 | |||||
Accounts payable | 8,553 | 7,775 | |||||
Accrued expenses and other liabilities | 9,955 | 7,978 | |||||
Short-term debt | 2,775 | 2,993 | |||||
Liabilities of businesses held for sale | 2,104 | 0 | |||||
Total current liabilities | 48,716 | 41,225 | |||||
Non-current insurance and contractholder liabilities | 10,904 | 11,976 | |||||
Deferred tax liabilities, net | 7,173 | 7,786 | |||||
Other non-current liabilities | 3,441 | 2,766 | |||||
Long-term debt | 28,155 | 28,100 | |||||
Separate account liabilities | 7,430 | 7,278 | |||||
Liabilities of businesses held for sale, non-current | 591 | 0 | |||||
TOTAL LIABILITIES | 106,410 | 99,131 | |||||
Contingencies — Note 24 | |||||||
Redeemable noncontrolling interests | 107 | 66 | |||||
Shareholders' equity | |||||||
Common stock | [2] | 4 | 4 | ||||
Additional paid-in capital | 30,669 | 30,233 | |||||
Accumulated other comprehensive loss | (1,864) | (1,658) | |||||
Retained earnings | 41,652 | 37,940 | |||||
Less: Treasury stock, at cost | (24,238) | (21,844) | |||||
TOTAL SHAREHOLDERS' EQUITY | 46,223 | 44,675 | |||||
Other noncontrolling interests | 21 | 13 | |||||
Total equity | 46,244 | 44,688 | |||||
Total liabilities and equity | $ 152,761 | $ 143,885 | |||||
|
 | Mr. David Michael Cordani |
---|---|
 | www.cigna.com |
 | 65535 |